INTRODUCTION
Hepatic stellate cells (HSCs) play a critical role in apoptosis and inflammation (1) . Activated HSCs secrete pro-fibrogenic cytokines, produce α-smooth muscle actin (SMA) and pro-collagen I, and are known to be a major source of collagens and inhibitors of matrix-degrading enzymes (tissue inhibitor of matrix metalloproteinases, TIMP) that are secreted during fibrosis (2) . Non-alcoholic steatohepatitis (NASH) is a progressive liver disease that eventually leads to cirrhosis, liver failure and hepatocellular carcinoma (HCC) (3) . Hepatocyte apoptosis is a key event of liver injury in the pathogenesis of NASH (4) , which in turn activates HSCs.
Interestingly, vitamin D (VD) deficiency has been associated with several pathological conditions, including autoimmune diseases, chronic liver diseases, insulin resistance (IR), and diabetes (5) (6) (7) . In patients with chronic liver disease, VD deficiency is associated with the progression of hepatic fibrosis (8) . In contrast, apoptosis of activated HSCs is a prominent feature in the regression of liver fibrosis, and natural killer (NK) cells possess an anti-fibrotic activity through direct HSC killing (9) . NK cell activity has been shown to decrease in patients with chronic liver disease as well as in HCC. Activation of NK cells is regulated by the balance of activating and inhibitory signalling (10) . NKG2D is an immunoreceptor that is expressed on most NK cells, CD αβT cells and γδT cells. Major histocompatibility complex (MHC) class I-related chain A and B (MICA/B) function as ligands for the NKG2D receptor. The interaction of MI-CA/B and NKG2D strongly activates NK cells, enhancing their cytolytic activity and cytokine production (11) (12) (13) . In contrast to classic MHC class I molecules, MICA/B are minimally expressed on normal cells but frequently on tumor cells. MI-CA/B are cleaved proteolytically from tumor cells and appear as soluble forms in the sera of patients with various malignancies, including HCC. Recent studies have demonstrated that MICA/B are also elevated in the sera of patients with autoimmune and cholestatic liver diseases, as well as in NASH (13) (14) (15) (16) .
Therefore, we aimed to analyze whether these stress ligands are specifically upregulated in human HSCs in a cell culture model of fatty liver disease. Moreover, we investigated if VD treatment modulates the effects of fatty acids on HSCs.
MATERIALS AND METHODS

Isolation of Primary Human HSCs
For isolation of primary HSCs, explanted liver grafts or partially resected liver segments were perfused with HBSS to wash out remaining blood and HBSS with 440-450 U/ml collagenase to digest the connective tissues. The obtained cell suspension was filtered through a 4 μm mesh and washed 3 times in HBSS. The supernatant was collected and subjected to density gradient centrifugation, prepared as 12.5% iodixanol solution (Optiprep, Axis-Shield, Wädenswil, Austria) overlayed with a 9% iodixanol solution, overlayed with GBSS (Sigma, Steinheim, Germany 
Cell Culture
The human immortalized HSC line LX-2 was cultured at 37° C with 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM) with a high glucose concentration (4.5 g/L) supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, 1% glutamine, and 1% heat-inactivated fetal bovine serum (FBS). Isolated primary human HSCs were grown in DMEM medium supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, 1% glutamine, and 10% FBS.
For experimental studies, cells were seeded in 6-well plates at a cell count of 1x10 5 cells/well in DMEM medium with 1% FBS overnight. On the following day, the medium was removed and replaced with medium containing either 0.25 mM, 0.5 mM, or 1 mM FFA, or vehicle. After 24 h incubation with FFA or vehicle, fresh medium was added, Vitamin D counters FFA-induced stress in HSC containing either VD 2 (10 -6 M, Biomol, Hamburg, Germany) or vehicle (ethanol) for 24 h. After the incubation, cells were washed with DPBS and harvested in RLT-Buffer (Qiagen, Hilden, Germany) for RNA isolation.
RNA Isolation and Reverse Transcription
Total RNA was isolated from cell lines using RNeasy Mini Kit (Qiagen). RNA concentrations and purities were determined photometrically (Biophotometer, Eppendorf, Hamburg, Germany) at 260 nm and 280 nm. RNA samples were adjusted to final concentrations of 0.125 μg/μl by adding RNAse-free water and kept at -80° C until further use. The QuantiTect Reverse Transcription Kit (Qiagen) was applied according to the manufacturer's instructions with 2 minute (min) pre-incubation at 42° C, reverse transcription for 20 min at 42° C and enzyme inactivation at 95° C for 3 min. The resulting cDNAs were dissolved in 30 μl Aqua Bidest and kept at -20° C until further use, as described previously by Bechmann et al. (17) .
Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR)
The mRNA levels of MICA/B, transforming growth factor (TGF)-ß, SMA, and collagen (COL)1α genes were assessed by qRT-PCR using hypoxanthine-phosphoribosyltransferase 1 primers as a housekeeping gene. The oligonucleotides utilized for PCR are given in Table 1 . qRT-PCR was performed using the iCycler IQ thermocycler (BioRad, Munich, Germany). A single reaction consisted of 15 μl Quanti Tect SYBR Green master mix (Qiagen), 2 μl cDNA, 1 μl forward primer, 1 μl reverse primer (at 10 pmol/μl each), and 11 μl Aqua Dest per well of 96-well qRT-PCR reaction plates (Nerbe Plus, Winsen/Luhe, Germany). Amplification was performed for 15 min at 95° C, followed by 40 cycles of 30 seconds (s) at 95° C, 30 s at 55° C, and 30 s at 72° C. Melting-curve data were collected from 95° C to 55° C, at -0.5° C steps for 10 s each. qRT-PCR data were recorded and analyzed with iCycler iQ Optical System Software 3.1a and subsequently analyzed with the Gene Expression Analysis for iCycler iQ v1.10 Excel Macros (both by BioRad).
Nile Red Staining for FFA Uptake
Cultured LX-2 cells were fixed with a cold methanol-acetone-dilution for 10 min and washed 3 times with PBS. Fixed cells were incubated in PBS with 20 μg/ml Nile red for 1 h. Counterstaining was performed with DAPI. Lipid drops were detected and photographed on an Axiovert 40 LSM microscope (Zeiss, Jena, Germany).
Statistical Analysis
Data shown are means ± SEM, if not stated otherwise, and were evaluated using MS Excel 2003 (Microsoft) and GraphPad-Prism (GraphPad Software, La Jolla, CA, USA). Differences between experimental conditions were detected using the unpaired Student (two-tailed) t-test and subsequently controlled with the F-test for excluding nonuniform variances. Statistical significance was assumed at p<0.05.
RESULTS
Does FFA or VD 2 Treatment Alter LX-2 Cell Morphology?
To determine FFA uptake in LX-2 cells, Nile red staining was used. As shown in Figure 1 (Figure 2 ).
Does FFA Uptake Induce Stress Ligand Upregulation in LX-2 cells?
MICA/B mRNA expression was measured by quantitative RT-PCR. Treatment of LX-2 cells with 1 mM FFAs resulted in a significant upregulation of MICA after 24 h (p<0.005; Figure 3A ), while MICB mRNA expression was not altered ( Figure  3B ). However, treatment with 0. 
Does VD 2 Influence Stress Ligand Expression in Isolated Primary HSCs?
Primary HSCs were incubated for 24 h with VD 2 alone, 0.25 mM FFAs or 0.25 mM FFA pre-incubation and VD 2 . As displayed in Figures 3C and 3D , VD2 significantly downregulated the mRNA expression of MICA and MICB versus controls (p<0.05). A similar downregulation was also observed for MICB mRNA by 0.25 mM FFAs as compared to the control group (p<0.05).
Does VD 2 Ameliorate Pro-Fibrogenic Genes in Activated LX-2 Cells Under Stress Conditions?
Incubation with 0.5 mM FFA or 1 mM FFA resulted in a significant upregulation of α-SMA and TGF-β mRNA expression, which was abrogated by addition of VD 2 ( Figure 4) . Surprisingly, expression of COL1α was reduced not only by VD treatment, but also by FFA incubation of LX-2 cells. No additional effect of VD 2 and FFA was detectable.
DISCUSSION
Activation of hepatic HSCs is an important step in the development of liver fibrosis. In response to liver injury, these cells lose their intracellular vitamin A stores, express α-SMA, and produce large amounts of extracellular matrix proteins, such as collagen, resulting in liver fibrosis. In addition, development of fibrosis is characterized by a diminution of matrix degrading metalloproteinases (MMPs) activity and enhanced activity of TIMPs, which are also produced by activated HSCs (2, 18) . Understanding the mechanisms linking chronic liver injury to fibrogenesis is essential to develop therapies countering this effect (1).
Vitamin D (VD) deficiency has been linked to many different diseases, including cancer, chronic liver diseases, diseases mediated by the immune system, IR, and also diabetes. Moreover, VD deficiency in patients with chronic liver disease can lead to the progression of hepatic fibrosis (5-7). Some studies have found low serum 25 (OH) VD levels in patients with chronic hepatitis and cirrhosis of different origins. A recent study by Targher et al. (19) demonstrated a decrease of serum 25 (OH) VD concentrations in non-alcoholic fatty liver disease (NAFLD) patients, which was associated with the histopathological features of NAFLD. However, several experimental studies reported that VD, via interaction with the VD receptor, protects against oxidative stress, and can influence migration, proliferation and gene expression of fibroblasts and reduce the inflammatory and fibrogenic activity of HSCs (5, 20, 21) . We previously investigated the role of MICA/B on liver injury, apoptosis and fibrosis in patients with NASH undergoing bariatric surgery for obesity. We found that hepatic NK cell number was elevated and NKG2D as well as MICA/B transcripts were increased in NASH. Moreover, we could identify a significant positive correlation between MI-CA/B proteins and markers of disease severity in patients with NASH. Therefore, measurement of MICA/B serum levels may be utilized as a novel marker to assess liver injury in NASH in a non-invasive fashion. Importantly, our data indicated that MICA/B are expressed on hepatocytes in patients with NASH and their expression may play an important role in their susceptibility to NK cells during hepatic inflammation as mediated by fatty infiltration of the liver (22) .
However, the role of stress ligands in HSCs is yet unknown. Therefore, in the present study, using LX-2 cells and primary human HSCs, we investigated the effects of FFAs and VD 2 treatment on MICA/B as well as pro-fibrogenic genes. Our results demonstrated that (1) FFAs activated stellate cells; (2) VD 2 downregulates the expression of MICA/B genes; and (3) VD 2 reduces the expression of TGF-ß and α-SMA as markers of hepatic fibrogenesis. Interestingly, COL1α expression was not only reduced by VD 2 , but also by FFA treatment.
Free fatty acids (FFAs) promote the process of liver fibrogenesis as they induce hepatocyte apoptosis (23, 24) . We previously examined the combined effects of FFAs and resveratrol on HSCs, as it was proposed that resveratrol may have a protective effect in fatty acid-induced liver injury. In contrast, we found that resveratrol amplified the profibrogenic effects of FFA on LX-2 cells (25) .
Taken together, our results demonstrate that FFAs activate LX-2 cells in vitro to produce profibrogenic factors. VD 2 ameliorates this effect and also reduces MICA/B expression in primary HSCs, probably due to a protective effect of VD 2 on NK cell killing of HSCs. In a setting of fibrogenic activity, this may not be a reasonable therapeutic option. Therefore, more detailed studies investigating the effects of FFA and VD 2 treatment on the interaction of HSCs and NK cells could help to clarify the contribution of HSCs in NASH-associated fibrogenesis.
